Skip to main content

Table 2 Summary of subgroup analysis for the prevalence of stunting, under-weight and wasting among HIV infected children in Sub-Saharan Africa, 2021

From: Under-nutrition and associated factors among children infected with human immunodeficiency virus in sub-Saharan Africa: a systematic review and meta-analysis

Type

Feature

Pooled prevalence of stunting, %(95% CI, I2, P value)

Pooled prevalence of under-weight, % (95% CI, I2, P value)

Pooled prevalence of wasting, %(95% CI, I2, P value)

Sub-group analysis by country

Ethiopia

41.83 (26.83–56.84, 99.1, <  0.01)

33.62 (25.04–42.20, 95.0, <  0.01)

21.24 (13.56–28.93, 95.9, <  0.01)

Tanzania

48.10 (39.05–57.15, 95.4, <  0.01)

24.11 (10.88–37.33, 97.9, <  0.01)

15.07 (0.52–29.62, 98.3, <  0.01)

Nigeria

41.18 (29.60–25.77, 92.7, <  0.01)

33.83 (11.81–55.85, 98, <  0.01)

32.05 (12.49–51.61, 97.5, <  0.01)

Mozambique*

57.40 (49.21–65.59, −)

47.10 (38.91–55.29, −)

18.60 (10.41–26.79, −)

Central Africa*

32.90 (30.39–35.40, −)

36.00 (33.49–38.51, −)

16.50 (13.99–19.00, −)

Burkina Faso*

29.90 (22.89–36.90, −)

11.60 (4.59–18.61, −)

10.40 (3.39–17.41, −)

Cameroon

65.56 (52.82–78.29, 86.7, <  0.01)

48.16 (36.06–60.26, 85.3, <  0.01)

29.24 (7.00–51.47, 95.8, <  0.01)

Senegalese*

42.00 (35.80–48.19, −)

–

52.00 (45.81–58.19, −)

South Africa

51.48 (7.99–94.97, 95.7, <  0.01)

31.12 (7.36–69.60, 94.5, <  0.01)

15.52 (4.85–26.19, 40.7, 0.194)

Kenya*

50.90 (46.15–55.64, −)

26.50 (21.75–31.25, −)

13.60 (8.85–18.35, −)

Malawi*

69.10 (64.35–73.85, −)

51.80 (47.05–56.55, −)

–

Equatorial Guinea*

56.30 (49.64–62.96, −)

56.30 (49.64–62.96, −)

27.70 (21.04–34.36, −)

Mali*

20.00 (15.53–24.47, −)

–

31.50 (27.03–35.97, −)

Uganda

48.51 (11.17–85.84, 92.6, <  0.01)

40.19 (18.57–61.80, 78.1, <  0.01)

4.00 (12.42–20.42, −)

Rwanda*

60.00 (55.03–64.96, −)

24.0 (19.04–28.97,-)

11.00 (6.04–5.97, −)

Sub-group analysis by study design

Cross-sectional

49.8 (42.5–57.0, 97.8)

35.29 (29.70–40.87, 95.9)

22.15 (16.29–28.00, 96.1)

Cohort

48.7 (39.7–57.8, 97.6)

44.89 (35.93–53.86, 97.2)

27.55 (20.99–34.11, 95.3)

Sub-group analysis by publication year

January 2010-december 2015

50.48 (44.19–56.77, 95.9,<  0.01)

34.82 (28.99–40.65, 95.1, <  0.01)

17.67 (11.45–23.89, 95.3, <  0.01)

January 2016-aguest 2021

43.79 (33.998–53.575, 99.1, <  0.01)

36.93 (28.03–45.83, 98.3,<  0.01)

26.97 (21.37–32.58, 96.8, <  0.01)

  1. *Countries having single study